View Author
scopus: 7005582226

Höppener, J.W.M.

(Jo Höppener)


medullary thyroid carcinoma mutation thyroid 18ink calcitonin ret 2b mice cancer medullary patient plasma calcitonin levels carcinoma level plasma p 18ink tumor expression p 18ink expression mtc development oncogenic ret biomarker medullary thyroid cancer development imaging oncogenic protein receptor ret mutations mtc patients inhibitor month utrecht 12 months analysis cdk 4 table antibody study endocrinol cycle p 18ink proteins van veelen disease progression treatment result p 18ink mutants university cdk 6 suppressor ret proto-oncogene wildtype knockout kinase ret 2b prognostic mouse tissue netherland genotype veelen metastase group detection therapy genotype groups peptide department p 18 mutations p 18à/à mice 18 f-fdg uptake incidence tumorigenesi mtc incidence 9 months metab antigen medicine growth diagnosis gastrin




4 Most Recent Publications

Multiple endocrine neoplasia type 2 (Article)
Lips, C.J.M. Veelen, W. van Links, T.P. Höppener, J.W.M.
2009-09-01
Medullary thyroid carcinoma and biomarkers: Past, present and future (Article)
Veelen, W. van Groot, J.W.B. de Acton, D.S. Hofstra, R.M. Höppener, J.W.M. Links, T.P. Lips, C.J.M.
2009-07-01
P18 is a tumor suppressor gene involved in human medullary thyroid carcinoma and pheochromocytoma development (Article)
Veelen, W. van Klompmaker, R. Gloerich, M. Gasteren, C.J.R. van Kalkhoven, E. Berger, R. Lips, C.J.M. Medema, R.H. Höppener, J.W.M. Acton, D.S.
2009-01-15
Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development (Article)
Veelen, W. van Gasteren, C.J.R. van Acton, D.S. Franklin, D.S. Berger, R. Lips, C.J.M. Höppener, J.W.M.
2008-03-01